Michael Boyle

Michael Boyle currently serves as the Head of Toxicology at Immunome, Inc., a position held since September 2024. Previous experience includes roles at the National Toxicology Program as an IRTA Toxicologic Pathology Fellow and at MPI Research as an Anatomic and Toxicologic Pathology Resident. Further contributions were made at Amgen, where Michael Boyle held several key positions, including Principal Pathologist and Pathology Director, focusing on toxicological and pathology aspects of various therapeutic areas. Michael Boyle also worked at a stealth startup as Vice President and Executive Director, overseeing Pathology and Toxicology. Academic training was completed at Michigan State University, enhancing expertise in toxicology and pathology, with notable involvement in developing treatments for cardiovascular diseases.